Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Australia
/
Healthcare
Create a narrative
CurveBeam AI Community
ASX:CVB Community
1
Narratives
written by author
0
Comments
on narratives written by author
3
Fair Values set
on narratives written by author
Create a narrative
CurveBeam AI
Popular
Undervalued
Overvalued
Community Investing Ideas
CurveBeam AI
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
HiRise Orders And Australasian Expansion Will Fuel Market Success
Key Takeaways Strong HiRise demand, expanded agreements, and protocol validation are set to drive revenue and sales growth, boosting future earnings. Regulatory progress with FDA and improved cash flows position the company for enhanced recurring revenue and efficient expense management.
View narrative
AU$0.18
FV
41.7% undervalued
intrinsic discount
86.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
CVB
CVB
CurveBeam AI
Your Fair Value
AU$
Current Price
AU$0.10
70.8% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-57m
77m
2015
2018
2021
2024
2025
2027
2030
Revenue AU$76.8m
Earnings AU$11.2m
Advanced
Set Fair Value